nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Epirubicin—thyroid cancer	0.262	0.519	CiPCiCtD
Teniposide—lung cancer—thyroid cancer	0.258	1	CtDrD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—thyroid cancer	0.243	0.481	CiPCiCtD
Teniposide—TOP2A—Epirubicin—thyroid cancer	0.0388	0.234	CbGbCtD
Teniposide—ABCC6—Doxorubicin—thyroid cancer	0.0387	0.234	CbGbCtD
Teniposide—ABCG2—Vandetanib—thyroid cancer	0.0209	0.126	CbGbCtD
Teniposide—TOP2A—Doxorubicin—thyroid cancer	0.0206	0.125	CbGbCtD
Teniposide—ABCG2—Sorafenib—thyroid cancer	0.0126	0.0761	CbGbCtD
Teniposide—ABCG2—Doxorubicin—thyroid cancer	0.00765	0.0462	CbGbCtD
Teniposide—CYP3A5—Sorafenib—thyroid cancer	0.00698	0.0422	CbGbCtD
Teniposide—CYP2C19—Sorafenib—thyroid cancer	0.00563	0.034	CbGbCtD
Teniposide—CYP2C9—Sorafenib—thyroid cancer	0.00468	0.0283	CbGbCtD
Teniposide—CYP3A4—Vandetanib—thyroid cancer	0.00452	0.0273	CbGbCtD
Teniposide—CYP3A4—Sorafenib—thyroid cancer	0.00272	0.0165	CbGbCtD
Teniposide—CYP3A4—Doxorubicin—thyroid cancer	0.00165	0.00998	CbGbCtD
Teniposide—NCOA1—saliva-secreting gland—thyroid cancer	0.00136	0.134	CbGeAlD
Teniposide—NCOA3—neck—thyroid cancer	0.00121	0.12	CbGeAlD
Teniposide—Sudden death—Vandetanib—thyroid cancer	0.0011	0.0396	CcSEcCtD
Teniposide—NCOA1—trachea—thyroid cancer	0.00105	0.103	CbGeAlD
Teniposide—Mucosal inflammation—Vandetanib—thyroid cancer	0.00102	0.0366	CcSEcCtD
Teniposide—NCOA3—saliva-secreting gland—thyroid cancer	0.000944	0.0933	CbGeAlD
Teniposide—Acute myeloid leukaemia—Epirubicin—thyroid cancer	0.000858	0.0308	CcSEcCtD
Teniposide—Gastrointestinal toxicity—Epirubicin—thyroid cancer	0.000858	0.0308	CcSEcCtD
Teniposide—NCOA1—thyroid gland—thyroid cancer	0.000827	0.0817	CbGeAlD
Teniposide—Gastrointestinal toxicity—Doxorubicin—thyroid cancer	0.000794	0.0285	CcSEcCtD
Teniposide—Acute myeloid leukaemia—Doxorubicin—thyroid cancer	0.000794	0.0285	CcSEcCtD
Teniposide—NCOA3—trachea—thyroid cancer	0.000728	0.0719	CbGeAlD
Teniposide—Mucosal inflammation—Sorafenib—thyroid cancer	0.000688	0.0247	CcSEcCtD
Teniposide—Cardiotoxicity—Epirubicin—thyroid cancer	0.000598	0.0214	CcSEcCtD
Teniposide—NCOA3—thyroid gland—thyroid cancer	0.000576	0.0569	CbGeAlD
Teniposide—Cardiotoxicity—Doxorubicin—thyroid cancer	0.000553	0.0198	CcSEcCtD
Teniposide—Leukaemia—Epirubicin—thyroid cancer	0.000523	0.0188	CcSEcCtD
Teniposide—NCOA1—lymph node—thyroid cancer	0.000514	0.0507	CbGeAlD
Teniposide—NCOA3—head—thyroid cancer	0.000511	0.0505	CbGeAlD
Teniposide—Neoplasm—Vandetanib—thyroid cancer	0.000511	0.0183	CcSEcCtD
Teniposide—ABCC6—thyroid gland—thyroid cancer	0.000507	0.05	CbGeAlD
Teniposide—Acute leukaemia—Epirubicin—thyroid cancer	0.000493	0.0177	CcSEcCtD
Teniposide—Sepsis—Vandetanib—thyroid cancer	0.00049	0.0176	CcSEcCtD
Teniposide—Leukaemia—Doxorubicin—thyroid cancer	0.000484	0.0174	CcSEcCtD
Teniposide—Acute leukaemia—Doxorubicin—thyroid cancer	0.000456	0.0164	CcSEcCtD
Teniposide—ABCC6—head—thyroid cancer	0.000449	0.0444	CbGeAlD
Teniposide—Neurotoxicity—Epirubicin—thyroid cancer	0.000363	0.013	CcSEcCtD
Teniposide—NCOA3—lymph node—thyroid cancer	0.000358	0.0354	CbGeAlD
Teniposide—Neuropathy—Sorafenib—thyroid cancer	0.000358	0.0128	CcSEcCtD
Teniposide—Bronchospasm—Vandetanib—thyroid cancer	0.000349	0.0125	CcSEcCtD
Teniposide—Neoplasm—Sorafenib—thyroid cancer	0.000344	0.0124	CcSEcCtD
Teniposide—TOP2A—thyroid gland—thyroid cancer	0.000338	0.0334	CbGeAlD
Teniposide—Neurotoxicity—Doxorubicin—thyroid cancer	0.000336	0.0121	CcSEcCtD
Teniposide—Neutropenia—Vandetanib—thyroid cancer	0.000331	0.0119	CcSEcCtD
Teniposide—Hepatic function abnormal—Sorafenib—thyroid cancer	0.000316	0.0114	CcSEcCtD
Teniposide—NCOA3—Idarubicin—Epirubicin—thyroid cancer	0.000312	0.221	CbGdCrCtD
Teniposide—Stomatitis—Vandetanib—thyroid cancer	0.000308	0.0111	CcSEcCtD
Teniposide—Myelosuppression—Epirubicin—thyroid cancer	0.0003	0.0108	CcSEcCtD
Teniposide—NCOA3—Idarubicin—Doxorubicin—thyroid cancer	0.000289	0.205	CbGdCrCtD
Teniposide—Haemoglobin—Vandetanib—thyroid cancer	0.000285	0.0102	CcSEcCtD
Teniposide—Haemorrhage—Vandetanib—thyroid cancer	0.000284	0.0102	CcSEcCtD
Teniposide—Myelosuppression—Doxorubicin—thyroid cancer	0.000278	0.00997	CcSEcCtD
Teniposide—ABCG2—saliva-secreting gland—thyroid cancer	0.000276	0.0273	CbGeAlD
Teniposide—Etoposide—PTGS2—thyroid cancer	0.00026	1	CrCbGaD
Teniposide—Mucosal inflammation—Epirubicin—thyroid cancer	0.000254	0.00913	CcSEcCtD
Teniposide—Arrhythmia—Vandetanib—thyroid cancer	0.000253	0.00909	CcSEcCtD
Teniposide—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.000253	0.179	CbGdCrCtD
Teniposide—Alopecia—Vandetanib—thyroid cancer	0.000251	0.00899	CcSEcCtD
Teniposide—Mucosal inflammation—Doxorubicin—thyroid cancer	0.000235	0.00844	CcSEcCtD
Teniposide—Neutropenia—Sorafenib—thyroid cancer	0.000224	0.00802	CcSEcCtD
Teniposide—Hypertension—Vandetanib—thyroid cancer	0.000213	0.00765	CcSEcCtD
Teniposide—Chest pain—Vandetanib—thyroid cancer	0.00021	0.00754	CcSEcCtD
Teniposide—TOP2A—lymph node—thyroid cancer	0.00021	0.0207	CbGeAlD
Teniposide—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000209	0.0075	CcSEcCtD
Teniposide—Bone marrow depression—Epirubicin—thyroid cancer	0.000209	0.00748	CcSEcCtD
Teniposide—Stomatitis—Sorafenib—thyroid cancer	0.000208	0.00745	CcSEcCtD
Teniposide—Oedema—Vandetanib—thyroid cancer	0.000202	0.00723	CcSEcCtD
Teniposide—Infection—Vandetanib—thyroid cancer	0.0002	0.00718	CcSEcCtD
Teniposide—Thrombocytopenia—Vandetanib—thyroid cancer	0.000197	0.00708	CcSEcCtD
Teniposide—Bone marrow depression—Doxorubicin—thyroid cancer	0.000193	0.00693	CcSEcCtD
Teniposide—Haemoglobin—Sorafenib—thyroid cancer	0.000192	0.0069	CcSEcCtD
Teniposide—Haemorrhage—Sorafenib—thyroid cancer	0.000191	0.00687	CcSEcCtD
Teniposide—Dyspnoea—Vandetanib—thyroid cancer	0.00018	0.00645	CcSEcCtD
Teniposide—Flushing—Sorafenib—thyroid cancer	0.000178	0.00637	CcSEcCtD
Teniposide—Decreased appetite—Vandetanib—thyroid cancer	0.000175	0.00629	CcSEcCtD
Teniposide—Arrhythmia—Sorafenib—thyroid cancer	0.000171	0.00613	CcSEcCtD
Teniposide—Alopecia—Sorafenib—thyroid cancer	0.000169	0.00607	CcSEcCtD
Teniposide—ABCG2—thyroid gland—thyroid cancer	0.000168	0.0166	CbGeAlD
Teniposide—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.000165	0.117	CbGdCrCtD
Teniposide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000165	0.00591	CcSEcCtD
Teniposide—Extravasation—Epirubicin—thyroid cancer	0.000161	0.00579	CcSEcCtD
Teniposide—Body temperature increased—Vandetanib—thyroid cancer	0.000159	0.00572	CcSEcCtD
Teniposide—Abdominal pain—Vandetanib—thyroid cancer	0.000159	0.00572	CcSEcCtD
Teniposide—Anaemia—Sorafenib—thyroid cancer	0.000154	0.00552	CcSEcCtD
Teniposide—Extravasation—Doxorubicin—thyroid cancer	0.000149	0.00536	CcSEcCtD
Teniposide—Leukopenia—Sorafenib—thyroid cancer	0.000149	0.00535	CcSEcCtD
Teniposide—Asthenia—Vandetanib—thyroid cancer	0.000145	0.00519	CcSEcCtD
Teniposide—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.000144	0.102	CbGdCrCtD
Teniposide—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000144	0.00457	CbGpPWpGaD
Teniposide—Hypertension—Sorafenib—thyroid cancer	0.000144	0.00516	CcSEcCtD
Teniposide—Pruritus—Vandetanib—thyroid cancer	0.000143	0.00512	CcSEcCtD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—thyroid cancer	0.00014	0.00445	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00014	0.00442	CbGpPWpGaD
Teniposide—Diarrhoea—Vandetanib—thyroid cancer	0.000138	0.00495	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—RXRA—thyroid cancer	0.000136	0.0043	CbGpPWpGaD
Teniposide—Infection—Sorafenib—thyroid cancer	0.000135	0.00485	CcSEcCtD
Teniposide—Thrombocytopenia—Sorafenib—thyroid cancer	0.000133	0.00478	CcSEcCtD
Teniposide—NCOA3—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000132	0.00419	CbGpPWpGaD
Teniposide—Neuropathy—Epirubicin—thyroid cancer	0.000132	0.00474	CcSEcCtD
Teniposide—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000132	0.00417	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.00013	0.00413	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00013	0.00411	CbGpPWpGaD
Teniposide—Anorexia—Sorafenib—thyroid cancer	0.00013	0.00465	CcSEcCtD
Teniposide—Vomiting—Vandetanib—thyroid cancer	0.000128	0.0046	CcSEcCtD
Teniposide—Neoplasm—Epirubicin—thyroid cancer	0.000127	0.00457	CcSEcCtD
Teniposide—Rash—Vandetanib—thyroid cancer	0.000127	0.00456	CcSEcCtD
Teniposide—Dermatitis—Vandetanib—thyroid cancer	0.000127	0.00456	CcSEcCtD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000127	0.00401	CbGpPWpGaD
Teniposide—Headache—Vandetanib—thyroid cancer	0.000126	0.00453	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000125	0.00397	CbGpPWpGaD
Teniposide—NCOA1—Organelle biogenesis and maintenance—RXRA—thyroid cancer	0.000124	0.00394	CbGpPWpGaD
Teniposide—Neuropathy—Doxorubicin—thyroid cancer	0.000122	0.00439	CcSEcCtD
Teniposide—Sepsis—Epirubicin—thyroid cancer	0.000122	0.00438	CcSEcCtD
Teniposide—Dyspnoea—Sorafenib—thyroid cancer	0.000121	0.00435	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00012	0.0038	CbGpPWpGaD
Teniposide—Nausea—Vandetanib—thyroid cancer	0.00012	0.0043	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000119	0.00378	CbGpPWpGaD
Teniposide—Phlebitis—Epirubicin—thyroid cancer	0.000119	0.00426	CcSEcCtD
Teniposide—NCOA3—PPARA activates gene expression—PPARG—thyroid cancer	0.000119	0.00375	CbGpPWpGaD
Teniposide—Decreased appetite—Sorafenib—thyroid cancer	0.000118	0.00424	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—thyroid cancer	0.000118	0.00423	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000117	0.0042	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—THRB—thyroid cancer	0.000117	0.0037	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000116	0.00367	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000115	0.00365	CbGpPWpGaD
Teniposide—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000114	0.0036	CbGpPWpGaD
Teniposide—Sepsis—Doxorubicin—thyroid cancer	0.000113	0.00406	CcSEcCtD
Teniposide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000111	0.00399	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—thyroid cancer	0.00011	0.00394	CcSEcCtD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00011	0.00347	CbGpPWpGaD
Teniposide—NCOA1—Biological oxidations—RXRA—thyroid cancer	0.000109	0.00344	CbGpPWpGaD
Teniposide—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000108	0.00388	CcSEcCtD
Teniposide—Urticaria—Sorafenib—thyroid cancer	0.000108	0.00388	CcSEcCtD
Teniposide—Body temperature increased—Sorafenib—thyroid cancer	0.000107	0.00386	CcSEcCtD
Teniposide—Abdominal pain—Sorafenib—thyroid cancer	0.000107	0.00386	CcSEcCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000107	0.0034	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.000107	0.00339	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000105	0.00331	CbGpPWpGaD
Teniposide—ABCG2—lymph node—thyroid cancer	0.000105	0.0103	CbGeAlD
Teniposide—NCOA1—Adipogenesis—HIF1A—thyroid cancer	0.000101	0.00319	CbGpPWpGaD
Teniposide—Hypersensitivity—Sorafenib—thyroid cancer	0.0001	0.00359	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—CCND1—thyroid cancer	9.98e-05	0.00316	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—PPARG—thyroid cancer	9.8e-05	0.0031	CbGpPWpGaD
Teniposide—Asthenia—Sorafenib—thyroid cancer	9.75e-05	0.0035	CcSEcCtD
Teniposide—NCOA3—Metabolism—MINPP1—thyroid cancer	9.64e-05	0.00305	CbGpPWpGaD
Teniposide—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	9.64e-05	0.00305	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—PTEN—thyroid cancer	9.63e-05	0.00305	CbGpPWpGaD
Teniposide—Pruritus—Sorafenib—thyroid cancer	9.62e-05	0.00345	CcSEcCtD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	9.59e-05	0.00304	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—CCND1—thyroid cancer	9.46e-05	0.003	CbGpPWpGaD
Teniposide—Liver function test abnormal—Epirubicin—thyroid cancer	9.44e-05	0.00339	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	9.41e-05	0.00298	CbGpPWpGaD
Teniposide—Diarrhoea—Sorafenib—thyroid cancer	9.3e-05	0.00334	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	8.96e-05	0.00284	CbGpPWpGaD
Teniposide—Liver function test abnormal—Doxorubicin—thyroid cancer	8.73e-05	0.00313	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—TPR—thyroid cancer	8.72e-05	0.00276	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—CP—thyroid cancer	8.72e-05	0.00276	CbGpPWpGaD
Teniposide—Vomiting—Sorafenib—thyroid cancer	8.64e-05	0.0031	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.58e-05	0.00272	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—PPARG—thyroid cancer	8.58e-05	0.00272	CbGpPWpGaD
Teniposide—Rash—Sorafenib—thyroid cancer	8.57e-05	0.00308	CcSEcCtD
Teniposide—Dermatitis—Sorafenib—thyroid cancer	8.56e-05	0.00307	CcSEcCtD
Teniposide—Headache—Sorafenib—thyroid cancer	8.52e-05	0.00306	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	8.51e-05	0.00269	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—BRAF—thyroid cancer	8.47e-05	0.00268	CbGpPWpGaD
Teniposide—Pancytopenia—Epirubicin—thyroid cancer	8.39e-05	0.00301	CcSEcCtD
Teniposide—Neutropenia—Epirubicin—thyroid cancer	8.26e-05	0.00296	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CCND1—thyroid cancer	8.25e-05	0.00261	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—AKT1—thyroid cancer	8.22e-05	0.0026	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—NDUFA13—thyroid cancer	8.2e-05	0.0026	CbGpPWpGaD
Teniposide—Nausea—Sorafenib—thyroid cancer	8.07e-05	0.0029	CcSEcCtD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	7.99e-05	0.00253	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—MINPP1—thyroid cancer	7.98e-05	0.00253	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—PTEN—thyroid cancer	7.97e-05	0.00252	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—TRIM33—thyroid cancer	7.77e-05	0.00246	CbGpPWpGaD
Teniposide—Pancytopenia—Doxorubicin—thyroid cancer	7.76e-05	0.00279	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—thyroid cancer	7.72e-05	0.00277	CcSEcCtD
Teniposide—NCOA3—Metabolism—CHST14—thyroid cancer	7.71e-05	0.00244	CbGpPWpGaD
Teniposide—Stomatitis—Epirubicin—thyroid cancer	7.68e-05	0.00276	CcSEcCtD
Teniposide—Neutropenia—Doxorubicin—thyroid cancer	7.64e-05	0.00274	CcSEcCtD
Teniposide—Sweating—Epirubicin—thyroid cancer	7.55e-05	0.00271	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDK1—thyroid cancer	7.53e-05	0.00238	CbGpPWpGaD
Teniposide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	7.45e-05	0.00236	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MEN1—thyroid cancer	7.41e-05	0.00235	CbGpPWpGaD
Teniposide—Neuropathy peripheral—Doxorubicin—thyroid cancer	7.14e-05	0.00256	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—thyroid cancer	7.11e-05	0.00255	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—thyroid cancer	7.1e-05	0.00255	CcSEcCtD
Teniposide—Haemorrhage—Epirubicin—thyroid cancer	7.07e-05	0.00254	CcSEcCtD
Teniposide—Sweating—Doxorubicin—thyroid cancer	6.99e-05	0.00251	CcSEcCtD
Teniposide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	6.8e-05	0.00215	CbGpPWpGaD
Teniposide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	6.8e-05	0.00215	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—NDUFA13—thyroid cancer	6.78e-05	0.00215	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—thyroid cancer	6.7e-05	0.00212	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—PCM1—thyroid cancer	6.67e-05	0.00211	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	6.61e-05	0.00209	CbGpPWpGaD
Teniposide—Haemoglobin—Doxorubicin—thyroid cancer	6.58e-05	0.00236	CcSEcCtD
Teniposide—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	6.58e-05	0.00208	CbGpPWpGaD
Teniposide—Flushing—Epirubicin—thyroid cancer	6.56e-05	0.00235	CcSEcCtD
Teniposide—Haemorrhage—Doxorubicin—thyroid cancer	6.54e-05	0.00235	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	6.54e-05	0.00207	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.53e-05	0.00207	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CHST14—thyroid cancer	6.38e-05	0.00202	CbGpPWpGaD
Teniposide—Chills—Epirubicin—thyroid cancer	6.34e-05	0.00228	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—thyroid cancer	6.32e-05	0.00227	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	6.31e-05	0.002	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—CP—thyroid cancer	6.3e-05	0.002	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.3e-05	0.002	CbGpPWpGaD
Teniposide—Alopecia—Epirubicin—thyroid cancer	6.25e-05	0.00224	CcSEcCtD
Teniposide—NCOA3—Metabolism—HPGD—thyroid cancer	6.21e-05	0.00197	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.2e-05	0.00196	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CDK1—thyroid cancer	6.08e-05	0.00193	CbGpPWpGaD
Teniposide—Flushing—Doxorubicin—thyroid cancer	6.07e-05	0.00218	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	6e-05	0.0019	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	5.96e-05	0.00189	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—thyroid cancer	5.96e-05	0.00189	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—PCM1—thyroid cancer	5.96e-05	0.00189	CbGpPWpGaD
Teniposide—Chills—Doxorubicin—thyroid cancer	5.87e-05	0.00211	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	5.86e-05	0.00185	CbGpPWpGaD
Teniposide—Arrhythmia—Doxorubicin—thyroid cancer	5.84e-05	0.0021	CcSEcCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.83e-05	0.00185	CbGpPWpGaD
Teniposide—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.83e-05	0.00185	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	5.8e-05	0.00184	CbGpPWpGaD
Teniposide—Alopecia—Doxorubicin—thyroid cancer	5.78e-05	0.00207	CcSEcCtD
Teniposide—Anaemia—Epirubicin—thyroid cancer	5.69e-05	0.00204	CcSEcCtD
Teniposide—Agitation—Epirubicin—thyroid cancer	5.66e-05	0.00203	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—RXRA—thyroid cancer	5.64e-05	0.00179	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—THRB—thyroid cancer	5.62e-05	0.00178	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	5.6e-05	0.00177	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—AKT1—thyroid cancer	5.55e-05	0.00176	CbGpPWpGaD
Teniposide—Leukopenia—Epirubicin—thyroid cancer	5.51e-05	0.00198	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.48e-05	0.00174	CbGpPWpGaD
Teniposide—Hypertension—Epirubicin—thyroid cancer	5.31e-05	0.00191	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	5.29e-05	0.00168	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—AKT1—thyroid cancer	5.26e-05	0.00167	CbGpPWpGaD
Teniposide—Anaemia—Doxorubicin—thyroid cancer	5.26e-05	0.00189	CcSEcCtD
Teniposide—Chest pain—Epirubicin—thyroid cancer	5.24e-05	0.00188	CcSEcCtD
Teniposide—Agitation—Doxorubicin—thyroid cancer	5.23e-05	0.00188	CcSEcCtD
Teniposide—NCOA1—Metabolism—HPGD—thyroid cancer	5.14e-05	0.00163	CbGpPWpGaD
Teniposide—Leukopenia—Doxorubicin—thyroid cancer	5.1e-05	0.00183	CcSEcCtD
Teniposide—Confusional state—Epirubicin—thyroid cancer	5.07e-05	0.00182	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.04e-05	0.0016	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CDK1—thyroid cancer	5.03e-05	0.00159	CbGpPWpGaD
Teniposide—Oedema—Epirubicin—thyroid cancer	5.02e-05	0.0018	CcSEcCtD
Teniposide—Infection—Epirubicin—thyroid cancer	4.99e-05	0.00179	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—RXRA—thyroid cancer	4.96e-05	0.00157	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	4.95e-05	0.00157	CbGpPWpGaD
Teniposide—Thrombocytopenia—Epirubicin—thyroid cancer	4.92e-05	0.00177	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—thyroid cancer	4.92e-05	0.00176	CcSEcCtD
Teniposide—Tachycardia—Epirubicin—thyroid cancer	4.9e-05	0.00176	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	4.9e-05	0.00155	CbGpPWpGaD
Teniposide—Hyperhidrosis—Epirubicin—thyroid cancer	4.86e-05	0.00174	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—thyroid cancer	4.85e-05	0.00174	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	4.84e-05	0.00153	CbGpPWpGaD
Teniposide—Anorexia—Epirubicin—thyroid cancer	4.79e-05	0.00172	CcSEcCtD
Teniposide—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.73e-05	0.0015	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.72e-05	0.00149	CbGpPWpGaD
Teniposide—Hypotension—Epirubicin—thyroid cancer	4.69e-05	0.00168	CcSEcCtD
Teniposide—Confusional state—Doxorubicin—thyroid cancer	4.69e-05	0.00168	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—RXRA—thyroid cancer	4.67e-05	0.00148	CbGpPWpGaD
Teniposide—Oedema—Doxorubicin—thyroid cancer	4.65e-05	0.00167	CcSEcCtD
Teniposide—Infection—Doxorubicin—thyroid cancer	4.62e-05	0.00166	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—AKT1—thyroid cancer	4.59e-05	0.00145	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	4.58e-05	0.00145	CbGpPWpGaD
Teniposide—Thrombocytopenia—Doxorubicin—thyroid cancer	4.55e-05	0.00163	CcSEcCtD
Teniposide—Tachycardia—Doxorubicin—thyroid cancer	4.54e-05	0.00163	CcSEcCtD
Teniposide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.51e-05	0.00143	CbGpPWpGaD
Teniposide—Hyperhidrosis—Doxorubicin—thyroid cancer	4.49e-05	0.00161	CcSEcCtD
Teniposide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	4.48e-05	0.00142	CbGpPWpGaD
Teniposide—Dyspnoea—Epirubicin—thyroid cancer	4.48e-05	0.00161	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	4.45e-05	0.00141	CbGpPWpGaD
Teniposide—Anorexia—Doxorubicin—thyroid cancer	4.43e-05	0.00159	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—thyroid cancer	4.37e-05	0.00157	CcSEcCtD
Teniposide—Hypotension—Doxorubicin—thyroid cancer	4.34e-05	0.00156	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—thyroid cancer	4.31e-05	0.00136	CbGpPWpGaD
Teniposide—TOP2A—Idarubicin—Epirubicin—thyroid cancer	4.29e-05	0.0304	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	4.29e-05	0.0304	CbGdCrCtD
Teniposide—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	4.29e-05	0.0304	CbGdCrCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.17e-05	0.00132	CbGpPWpGaD
Teniposide—Dyspnoea—Doxorubicin—thyroid cancer	4.14e-05	0.00149	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—thyroid cancer	4.14e-05	0.00149	CcSEcCtD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.11e-05	0.0013	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Epirubicin—thyroid cancer	4.11e-05	0.00147	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.09e-05	0.00129	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TPR—thyroid cancer	4.07e-05	0.00129	CbGpPWpGaD
Teniposide—Decreased appetite—Doxorubicin—thyroid cancer	4.04e-05	0.00145	CcSEcCtD
Teniposide—Urticaria—Epirubicin—thyroid cancer	3.99e-05	0.00143	CcSEcCtD
Teniposide—Body temperature increased—Epirubicin—thyroid cancer	3.97e-05	0.00143	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—thyroid cancer	3.97e-05	0.00143	CcSEcCtD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	3.97e-05	0.0281	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	3.97e-05	0.0281	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	3.97e-05	0.0281	CbGdCrCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.96e-05	0.00126	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	3.95e-05	0.00125	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	3.89e-05	0.00123	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	3.88e-05	0.00123	CbGpPWpGaD
Teniposide—Feeling abnormal—Doxorubicin—thyroid cancer	3.83e-05	0.00137	CcSEcCtD
Teniposide—Gastrointestinal pain—Doxorubicin—thyroid cancer	3.8e-05	0.00136	CcSEcCtD
Teniposide—NCOA1—Gene Expression—TPR—thyroid cancer	3.8e-05	0.0012	CbGpPWpGaD
Teniposide—Hypersensitivity—Epirubicin—thyroid cancer	3.7e-05	0.00133	CcSEcCtD
Teniposide—Urticaria—Doxorubicin—thyroid cancer	3.69e-05	0.00133	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—thyroid cancer	3.67e-05	0.00132	CcSEcCtD
Teniposide—Body temperature increased—Doxorubicin—thyroid cancer	3.67e-05	0.00132	CcSEcCtD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.65e-05	0.00116	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TPR—thyroid cancer	3.64e-05	0.00115	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	3.64e-05	0.00115	CbGpPWpGaD
Teniposide—Asthenia—Epirubicin—thyroid cancer	3.6e-05	0.00129	CcSEcCtD
Teniposide—NCOA1—Gene Expression—MEN1—thyroid cancer	3.57e-05	0.00113	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—TPR—thyroid cancer	3.57e-05	0.00113	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—PPARG—thyroid cancer	3.56e-05	0.00113	CbGpPWpGaD
Teniposide—Pruritus—Epirubicin—thyroid cancer	3.55e-05	0.00128	CcSEcCtD
Teniposide—NCOA3—Metabolism—PRKAR1A—thyroid cancer	3.51e-05	0.00111	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	3.44e-05	0.00109	CbGpPWpGaD
Teniposide—Diarrhoea—Epirubicin—thyroid cancer	3.44e-05	0.00123	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—thyroid cancer	3.42e-05	0.00123	CcSEcCtD
Teniposide—Asthenia—Doxorubicin—thyroid cancer	3.34e-05	0.0012	CcSEcCtD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.33e-05	0.00106	CbGpPWpGaD
Teniposide—Pruritus—Doxorubicin—thyroid cancer	3.29e-05	0.00118	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—PPARG—thyroid cancer	3.21e-05	0.00102	CbGpPWpGaD
Teniposide—Vomiting—Epirubicin—thyroid cancer	3.19e-05	0.00115	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.18e-05	0.00101	CbGpPWpGaD
Teniposide—Diarrhoea—Doxorubicin—thyroid cancer	3.18e-05	0.00114	CcSEcCtD
Teniposide—Rash—Epirubicin—thyroid cancer	3.17e-05	0.00114	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—thyroid cancer	3.16e-05	0.00114	CcSEcCtD
Teniposide—Headache—Epirubicin—thyroid cancer	3.15e-05	0.00113	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND1—thyroid cancer	3.13e-05	0.000993	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—PPARG—thyroid cancer	3.13e-05	0.000992	CbGpPWpGaD
Teniposide—Nausea—Epirubicin—thyroid cancer	2.98e-05	0.00107	CcSEcCtD
Teniposide—Vomiting—Doxorubicin—thyroid cancer	2.96e-05	0.00106	CcSEcCtD
Teniposide—NCOA1—Metabolism—TPR—thyroid cancer	2.95e-05	0.000935	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—PPARG—thyroid cancer	2.95e-05	0.000933	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	2.93e-05	0.000929	CbGpPWpGaD
Teniposide—Rash—Doxorubicin—thyroid cancer	2.93e-05	0.00105	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—thyroid cancer	2.93e-05	0.00105	CcSEcCtD
Teniposide—Headache—Doxorubicin—thyroid cancer	2.91e-05	0.00104	CcSEcCtD
Teniposide—NCOA1—Metabolism—PRKAR1A—thyroid cancer	2.9e-05	0.00092	CbGpPWpGaD
Teniposide—Nausea—Doxorubicin—thyroid cancer	2.76e-05	0.000991	CcSEcCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	2.76e-05	0.000874	CbGpPWpGaD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.71e-05	0.000858	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	2.7e-05	0.000854	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—SLC5A5—thyroid cancer	2.67e-05	0.000846	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.63e-05	0.000833	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.63e-05	0.000832	CbGpPWpGaD
Teniposide—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.59e-05	0.00082	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—MINPP1—thyroid cancer	2.57e-05	0.000815	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—RXRA—thyroid cancer	2.51e-05	0.000795	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.5e-05	0.000793	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK1—thyroid cancer	2.47e-05	0.000781	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—RXRA—thyroid cancer	2.39e-05	0.000756	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.37e-05	0.000752	CbGpPWpGaD
Teniposide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.36e-05	0.000748	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.29e-05	0.000726	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—RXRA—thyroid cancer	2.24e-05	0.000711	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—SLC5A5—thyroid cancer	2.21e-05	0.0007	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	2.2e-05	0.000697	CbGpPWpGaD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.2e-05	0.000696	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NDUFA13—thyroid cancer	2.19e-05	0.000693	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.18e-05	0.000691	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NRAS—thyroid cancer	2.18e-05	0.000691	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.07e-05	0.000656	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.06e-05	0.000653	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CHST14—thyroid cancer	2.06e-05	0.000652	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.03e-05	0.000644	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	2.03e-05	0.000644	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2e-05	0.000634	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—RXRA—thyroid cancer	1.94e-05	0.000615	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.88e-05	0.000596	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.88e-05	0.000596	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—thyroid cancer	1.88e-05	0.000594	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—RXRA—thyroid cancer	1.86e-05	0.000588	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.84e-05	0.000584	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.81e-05	0.000572	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—thyroid cancer	1.8e-05	0.000571	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TERT—thyroid cancer	1.78e-05	0.000563	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	1.77e-05	0.000561	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.76e-05	0.000557	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—HPGD—thyroid cancer	1.66e-05	0.000525	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—thyroid cancer	1.6e-05	0.000505	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.57e-05	0.000497	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.56e-05	0.000495	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—thyroid cancer	1.55e-05	0.000492	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.52e-05	0.000482	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PPARG—thyroid cancer	1.51e-05	0.000477	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	1.5e-05	0.000476	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CHST14—thyroid cancer	1.47e-05	0.000467	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—MINPP1—thyroid cancer	1.43e-05	0.000452	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPARG—thyroid cancer	1.42e-05	0.000449	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—thyroid cancer	1.41e-05	0.000446	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.32e-05	0.000418	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—thyroid cancer	1.32e-05	0.000418	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—MINPP1—thyroid cancer	1.3e-05	0.000412	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.28e-05	0.000405	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NDUFA13—thyroid cancer	1.21e-05	0.000384	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—HPGD—thyroid cancer	1.19e-05	0.000376	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPARG—thyroid cancer	1.17e-05	0.000371	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.17e-05	0.00037	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—thyroid cancer	1.17e-05	0.000369	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.15e-05	0.000364	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CHST14—thyroid cancer	1.14e-05	0.000361	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000353	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.11e-05	0.00035	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CHST14—thyroid cancer	1.04e-05	0.000329	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—thyroid cancer	1.03e-05	0.000326	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTEN—thyroid cancer	9.72e-06	0.000308	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TPR—thyroid cancer	9.53e-06	0.000302	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PRKAR1A—thyroid cancer	9.38e-06	0.000297	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTGS2—thyroid cancer	9.22e-06	0.000292	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—HPGD—thyroid cancer	9.19e-06	0.000291	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—MINPP1—thyroid cancer	8.58e-06	0.000272	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—HPGD—thyroid cancer	8.38e-06	0.000265	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTEN—thyroid cancer	8.04e-06	0.000255	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.45e-06	0.000236	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	7.29e-06	0.000231	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SLC5A5—thyroid cancer	7.13e-06	0.000226	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CHST14—thyroid cancer	6.86e-06	0.000217	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TPR—thyroid cancer	6.83e-06	0.000216	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.8e-06	0.000215	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—thyroid cancer	6.77e-06	0.000214	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	6.72e-06	0.000213	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—RXRA—thyroid cancer	5.99e-06	0.00019	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—thyroid cancer	5.96e-06	0.000189	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—thyroid cancer	5.6e-06	0.000177	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—HPGD—thyroid cancer	5.53e-06	0.000175	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TPR—thyroid cancer	5.28e-06	0.000167	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	5.19e-06	0.000164	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SLC5A5—thyroid cancer	5.11e-06	0.000162	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TPR—thyroid cancer	4.81e-06	0.000152	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	4.74e-06	0.00015	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.71e-06	0.000149	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—thyroid cancer	4.63e-06	0.000147	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—RXRA—thyroid cancer	4.29e-06	0.000136	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.29e-06	0.000136	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.95e-06	0.000125	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPARG—thyroid cancer	3.78e-06	0.00012	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.7e-06	0.000117	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	3.6e-06	0.000114	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.38e-06	0.000107	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—RXRA—thyroid cancer	3.32e-06	0.000105	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.23e-06	0.000102	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TPR—thyroid cancer	3.17e-06	0.000101	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.12e-06	9.89e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—RXRA—thyroid cancer	3.03e-06	9.59e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTGS2—thyroid cancer	2.98e-06	9.43e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.94e-06	9.32e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPARG—thyroid cancer	2.71e-06	8.59e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTEN—thyroid cancer	2.6e-06	8.22e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.38e-06	7.52e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTGS2—thyroid cancer	2.13e-06	6.75e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPARG—thyroid cancer	2.1e-06	6.64e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—RXRA—thyroid cancer	2e-06	6.32e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPARG—thyroid cancer	1.91e-06	6.05e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTEN—thyroid cancer	1.86e-06	5.89e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.65e-06	5.22e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.5e-06	4.76e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—thyroid cancer	1.5e-06	4.74e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTEN—thyroid cancer	1.44e-06	4.55e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTEN—thyroid cancer	1.31e-06	4.15e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPARG—thyroid cancer	1.26e-06	3.99e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—thyroid cancer	1.07e-06	3.39e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.92e-07	3.14e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTEN—thyroid cancer	8.65e-07	2.74e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—thyroid cancer	8.29e-07	2.62e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—thyroid cancer	7.56e-07	2.39e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—thyroid cancer	4.98e-07	1.58e-05	CbGpPWpGaD
